Activiteiten per jaar
Activiteiten
- 1 - 50 van 55 resultaten
Zoekresultaten
-
”Liquid biopsies in lung: Predictive markers in NSLC, monitoring, screening and resistance mutation testing: is there a one-size-fits-all cell free DNA test ?”
Schuuring, E. (Invited speaker)
28-okt.-2021 → 29-okt.-2021Activiteit: Academic presentation › Academic
-
“RET diagnostiek in het lab”. Webcast: Update aanpak RET-gedreven tumoren; diagnostiek en behandelopties.
Schuuring, E. (Invited speaker)
10-mrt.-2021Activiteit: Academic presentation › Academic
-
”Summary of survey questions: efforts for harmonization by Dutch COIN consortium”
Schuuring, E. (Invited speaker)
6-dec.-2021Activiteit: Academic presentation › Academic
-
“NTRK diagnostiek in het lab”
Schuuring, E. (Invited speaker)
9-jun.-2021Activiteit: Academic presentation › Academic
-
”Het gebruik van tumorweefsel of bloedplasma: is er ruimte voor Liquid Biopsy ?”
Schuuring, E. (Invited speaker) & Schuuring, E. (Contributor)
okt.-2021Activiteit: Academic presentation › Academic
-
“Circulating tumor DNA as an early on-treatment predictive biomarker for patients with advanced non-small cell lung cancer receiving immune checkpoint inhibitors”
Schuuring, E. (Invited speaker)
6-dec.-2021 → 7-dec.-2021Activiteit: Academic presentation › Academic
-
"Plaats van de moleculaire tumor board (MTB) in het zorgsysteem"
Schuuring, E. (Invited speaker)
8-sep.-2021Activiteit: Academic presentation › Academic
-
“Circulating tumor DNA as a monitoring tool for clinical outcome in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors”
Schuuring, E. (Invited speaker) & Schuuring, E. (Contributor)
4-nov.-2021 → 5-nov.-2021Activiteit: Academic presentation › Academic
-
“Detection of therapeutically targetable mutations in NSCLC: Is there a one size fits all cell free DNA test ?”
Schuuring, E. (Invited speaker)
13-okt.-2021Activiteit: Academic presentation › Academic
-
Testing algorithms in RET-driven NSCLC
Schuuring, E. (Invited speaker)
13-okt.-2021Activiteit: Academic presentation › Academic
-
“Circulating tumor DNA as an early on-treatment predictive biomarker for patients with advanced non-small cell lung cancer receiving immune checkpoint inhibitors”
Schuuring, E. (Invited speaker)
9-nov.-2021 → 11-nov.-2021Activiteit: Academic presentation › Academic
-
”ALK mutatieanalyse met behandelconsequentie”
Schuuring, E. (Invited speaker)
18-nov.-2021 → 19-nov.-2021Activiteit: Academic presentation › Academic
-
“Prediction of tumor response in NSCLC patients treated with immunotherapy by monitoring of ctDNA levels”
Schuuring, E. (Invited speaker)
8-okt.-2020 → 9-okt.-2020Activiteit: Academic presentation › Academic
-
"A comparison of cfDNA Approaches to Guide Targeted Therapy in NSCLC"
Schuuring, E. (Speaker)
11-mrt.-2020Activiteit: Academic presentation › Academic
-
“Prediction of tumor response in NSCLC patients treated with immunotherapy by monitoring of ctDNA levels”
Schuuring, E. (Invited speaker)
6-nov.-2020 → 8-nov.-2020Activiteit: Academic presentation › Academic
-
Seracare Webinar: The promise of Liquid Biopsy for cancer diagnostics and therapeutic monitoring: are we there yet?
Schuuring, E. (Invited speaker) & Schuuring, E. (Keynote speaker)
27-okt.-2020Activiteit: Academic presentation › Academic
-
“A comparison of cfDNA Approaches to Guide Targeted Therapy in NSCLC”.
Schuuring, E. (Invited speaker)
17-nov.-2020Activiteit: Academic presentation › Academic
-
“Monitoring circulating tumor DNA as a molecular bloodborne-based biomarker to predict tumor response in lung cancer patients treated with immunotherapy”
Schuuring, E. (Invited speaker)
4-nov.-2020Activiteit: Academic presentation › Academic
-
Circulating tumor DNA as a molecular blood-borne biomarker to predict tumor response in lung cancer patients treated with immunotherapy
Schuuring, E. (Invited speaker)
24-jan.-2020Activiteit: Academic presentation › Academic
-
Implementatie PIK3CA testing in NL: Diagnostiek bij gemetastaseerde borstkanker. Wat is de huidige stand van zaken en hoe richten we de PIK3CA bepaling in in NL? Perspectief van de KMBPer
Schuuring, E. (Invited speaker)
12-feb.-2020Activiteit: Academic presentation › Academic
-
Circulating tumor DNA to monitor tumor response in lung cancer patients treated with immunotherapy
Schuuring, E. (Invited speaker)
27-mei-2020Activiteit: Academic presentation › Academic
-
“Cell-free circulating DNA: Preanalytical considerations and detection of clinical-relevant mutations in NSCLC eligible for targeted therapy using UltraSEEK UltraSEEK® Lung test on MassARRAY® system”
Schuuring, E. (Invited speaker)
15-okt.-2020Activiteit: Academic presentation › Academic
-
“Molecular diagnostics for optimal therapy management in lung cancer: ALK testing methods, guidelines and quality assessment”
Schuuring, E. (Invited speaker)
27-aug.-2020Activiteit: Academic presentation › Academic
-
Pathologieforum 2020, MedTalks Virtual meeting
Schuuring, E. (Keynote speaker), Willems, S. (Speaker), von der Thusen, J. (Speaker) & Claessens, N. J. M. (Speaker)
1-okt.-2020Activiteit: Academic presentation › Academic
-
First experiences from the Dutch national hrHPV-population-based screening program
Schuuring, E. (Invited speaker)
26-jan.-2019Activiteit: Academic presentation › Academic
-
ctDNA as a biomarker for early tumor response assessment in lung cancer patients treated with immunotherapy
Schuuring, E. (Invited speaker)
21-jan.-2019Activiteit: Academic presentation › Academic
-
Derde Nederlandse cfDNA themadag 2019
Schuuring, E. (Invited speaker)
21-jun.-2019Activiteit: Academic presentation › Academic
-
Molecular testing in thoracic oncology: 2019 status in UMCG and Netherlands
Schuuring, E. (Invited speaker)
26-jan.-2019Activiteit: Academic presentation › Academic
-
Moleculaire Pathologie in regio Noord: Liquid biopsy, Moleculaire Tumor Board, PATH-studie
Schuuring, E. (Invited speaker)
27-mrt.-2019Activiteit: Academic presentation › Academic
-
Monitoring the effectiveness of lung cancer immunotherapies using droplet digital PCR
Schuuring, E. (Keynote speaker)
7-nov.-2019 → 8-nov.-2019Activiteit: Academic presentation › Academic
-
Circulating tumor DNA as a molecular blood-borne biomarker to predict tumor response in lung cancer patients treated with immunotherapy
Schuuring, E. (Keynote speaker)
28-okt.-2019 → 29-okt.-2019Activiteit: Academic presentation › Academic
-
Joint session: Liquid-Biopsies: cell-free DNA
Schuuring, E. (Invited speaker)
27-sep.-2019Activiteit: Academic presentation › Academic
-
Molecular Pathology in the Netherlands
Schuuring, E. (Invited speaker)
4-dec.-2019Activiteit: Academic presentation › Academic
-
Circulating Tumor DNA as a Molecular Bloodborne-Based Biomarker to Predict Tumor Response in Lung Cancer Patients Treated with Immunotherapy
Schuuring, E. (Invited speaker)
7-mei-2019Activiteit: Academic presentation › Academic
-
Molecular testing in thoracic oncology: 2019 status in UMCG and Netherlands
Schuuring, E. (Invited speaker)
25-jan.-2019Activiteit: Academic presentation › Academic
-
Primary hrHPV screening in the Dutch cervical cancer screening program
Schuuring, E. (Keynote speaker)
11-okt.-2019Activiteit: Academic presentation › Academic
-
ctDNA as a biomarker for early tumor response assessment in lung cancer patients treated with immunotherapy
Schuuring, E. (Invited speaker)
18-mrt.-2019Activiteit: Academic presentation › Academic
-
Hunting for cancer cells and molecules in the blood
Schuuring, E. (Invited speaker)
19-jun.-2018Activiteit: Academic presentation › Academic
-
ctDNA as a biomarker for early tumor response assessment in lung cancer patients treated with immunotherapy
Schuuring, E. (Invited speaker)
12-mrt.-2018 → 14-mrt.-2018Activiteit: Academic presentation › Academic
-
Tweede Nederlandse cfDNA dag
Schuuring, E. (Invited speaker)
14-jun.-2018Activiteit: Academic presentation › Academic
-
Moleculaire Pathologie in Friesland: Liquid biopsy, Moleculaire Tumor Board, PATH-studie en CPTC
Schuuring, E. (Invited speaker)
30-jan.-2018Activiteit: Academic presentation › Academic
-
ctDNA as a biomarker for early tumor response assessment in lung cancer patients treated with immunotherapy
Schuuring, E. (Invited speaker)
30-nov.-2018Activiteit: Academic presentation › Academic
-
ctDNA as a biomarker for early tumor response assessment in lung cancer patients treated with immunotherapy
Schuuring, E. (Invited speaker)
17-apr.-2018Activiteit: Academic presentation › Academic
-
Stand van zaken MP in regio Noord: Predictieve moleculaire testing en Rol Moleculaire Tumor Board
Schuuring, E. (Invited speaker)
6-dec.-2018Activiteit: Academic presentation › Academic
-
Molecular testing in thoracic oncology: problems, pitfalls and progress”, Joint Long Course Pulmonary Pathology, Thymic and Mediastinal Pathology and Molecular Pathology
Schuuring, E. (Invited speaker)
11-sep.-2018Activiteit: Academic presentation › Academic
-
ctDNA as a biomarker for early tumor response assessment in lung cancer patients treated with immunotherapy
Schuuring, E. (Invited speaker)
2-mei-2018Activiteit: Academic presentation › Academic
-
ALK testing methods, guidelines and quality assessment” Roche symposium: “ALK positive lung cancers: latest clinical data and testing, guidelines for improved patient management
Schuuring, E. (Invited speaker)
17-okt.-2018Activiteit: Academic presentation › Academic
-
ctDNA as a biomarker for early tumor response assessment in lung cancer patients treated with immunotherapy
Schuuring, E. (Invited speaker)
10-sep.-2018Activiteit: Academic presentation › Academic
-
Lung education series:
Schuuring, E. (Invited speaker)
1-dec.-2017 → 2-dec.-2017Activiteit: Academic presentation › Academic
-
edTalks Oncology TV, Paneldiscussie in kader van Nascholing, Quadia
Schuuring, E. (Invited speaker)
7-dec.-2017Activiteit: Academic presentation › Academic